TITLE

Sum > parts: Building a high performance CR team

PUB. DATE
December 2009
SOURCE
Clinical Trials Administrator;Dec2009, Vol. 7 Issue 12, p139
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article outlines steps that clinical research (CR) sites can take when developing a high performance clinical trial research team. Emphasis is given on the importance of starting a chartering process which involves understanding the team's purpose as well as the need to keep organization's mission and goal in mind with each study. Also suggested are the significance of forming team-building groups at the start of each trial or when membership changes, and the value of focusing the team on thinking about delivering CR results contract.
ACCESSION #
47469499

 

Related Articles

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • Update on Russia Trials.  // Applied Clinical Trials;Jul2008, Vol. 17 Issue 7, p22 

    The article discusses the report of Russian contract research organization (CRO) Synergy Research Group on the present condition of the clinical trials market in Russia. According to the report, the Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation...

  • Is a simple "Thank you" too much to ask? Rivero-Arias, Oliver // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/17/2009, Vol. 339 Issue 7726, p905 

    The author expresses appreciation to patients who helped generate the research findings of their studies. He relates that he conducted a review of clinical trials and economic evaluations and explored the acknowledgments section of the main clinical paper looking for words of gratitude to...

  • Improve your research contract, negotiation skills.  // Clinical Trials Administrator;Mar2010, Vol. 8 Issue 3, p34 

    The article offers helpful information on improving research contracts by understanding the motivations of the parties involved. It advises clinical administrators and investigators to know what benefits can be gained such as the publication rights of the study while the sponsors have different...

  • Systematic reviews in health care: Assessing the quality of controlled clinical trials. Juni, Peter; Altman, Douglas G; Egger, Matthias // BMJ: British Medical Journal (International Edition);7/7/2001, Vol. 323 Issue 7303, p42 

    Discusses the concept of study quality and the methods used to assess quality of randomised controlled trials. Validity of the findings as a dimension of quality; Bias in clinical trials, such as selection bias and performance bias; Applicability of the results of a study to other populations...

  • Reporting of Noninferiority Trials in ClinicalTrials.gov and Corresponding Publications. Gopal, Anand D.; Desai, Nihar R.; Tse, Tony; Ross, Joseph S. // JAMA: Journal of the American Medical Association;3/17/2015, Vol. 313 Issue 11, p1163 

    The article discusses research which examined the reporting of noninferiority clinical trials by analyzing registration records posted on ClinicalTrials.gov. Topics covered include the percentage of trials which provided justification for choosing noninferiority margins, the factors associated...

  • Subjective endpoints in clinical trials: the case for blinded independent central review. Walovitch, Richard; Bin Yao; Chokron, Patrick; Helen Le; Bubley, Glenn // Open Access Journal of Clinical Trials;2013, Vol. 5, p111 

    Primary efficacy and safety endpoints in clinical trials are often subjective assessments made by site personnel. For international confirmatory trials conducted over broad geographic regions and different clinical practice settings, variability in these subjective assessments can be...

  • Veteran researchers' advice to new researchers.  // Clinical Trials Administrator;Apr2008, Vol. 6 Issue 4, p42 

    The article reports on the advice given by Doctor Roy Fleischmann, clinical professor of medicine at the University of Texas Southwestern Medical Center in Dallas, Texas, to new researchers in the clinical trial industry. He states that when he started doing studies, they were designed to ask a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics